The inability for current mediation methods to incorporate the time-varying relationship between rituximab dosing, IgG levels, and infections, or model rituximab as an ordinal variable is the most likely explanation for why the ADE did not reach statistical significance in these models.
← all excerpts
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections.
1
—
—